chr7-150996417-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_000603.5(NOS3):c.284C>T(p.Thr95Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 17)
Consequence
NOS3
NM_000603.5 missense
NM_000603.5 missense
Scores
9
10
Clinical Significance
Conservation
PhyloP100: 2.14
Genes affected
NOS3 (HGNC:7876): (nitric oxide synthase 3) Nitric oxide is a reactive free radical which acts as a biologic mediator in several processes, including neurotransmission and antimicrobial and antitumoral activities. Nitric oxide is synthesized from L-arginine by nitric oxide synthases. Variations in this gene are associated with susceptibility to coronary spasm. Alternative splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Oct 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.28441638).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NOS3 | NM_000603.5 | c.284C>T | p.Thr95Ile | missense_variant | 4/27 | ENST00000297494.8 | NP_000594.2 | |
NOS3 | NM_001160111.1 | c.284C>T | p.Thr95Ile | missense_variant | 3/14 | NP_001153583.1 | ||
NOS3 | NM_001160110.1 | c.284C>T | p.Thr95Ile | missense_variant | 3/14 | NP_001153582.1 | ||
NOS3 | NM_001160109.2 | c.284C>T | p.Thr95Ile | missense_variant | 3/14 | NP_001153581.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NOS3 | ENST00000297494.8 | c.284C>T | p.Thr95Ile | missense_variant | 4/27 | 1 | NM_000603.5 | ENSP00000297494 | P1 | |
NOS3 | ENST00000484524.5 | c.284C>T | p.Thr95Ile | missense_variant | 3/14 | 1 | ENSP00000420215 | |||
NOS3 | ENST00000467517.1 | c.284C>T | p.Thr95Ile | missense_variant | 3/14 | 1 | ENSP00000420551 | |||
NOS3 | ENST00000461406.5 | c.-37+1103C>T | intron_variant | 2 | ENSP00000417143 |
Frequencies
GnomAD3 genomes Cov.: 17
GnomAD3 genomes
Cov.:
17
GnomAD4 exome Cov.: 34
GnomAD4 exome
Cov.:
34
GnomAD4 genome Cov.: 17
GnomAD4 genome
Cov.:
17
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Essential hypertension Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Centre for Mendelian Genomics, University Medical Centre Ljubljana | Aug 14, 2019 | This variant was classified as: Uncertain significance. The available evidence on this variant's pathogenicity is insufficient or conflicting. The following ACMG criteria were applied in classifying this variant: PM2,PP3. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Uncertain
T;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Uncertain
D;D;D
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M;M
MutationTaster
Benign
D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D;D
REVEL
Benign
Sift
Uncertain
D;D;D
Sift4G
Uncertain
D;D;D
Polyphen
P;.;.
Vest4
MutPred
Loss of phosphorylation at T95 (P = 0.0061);Loss of phosphorylation at T95 (P = 0.0061);Loss of phosphorylation at T95 (P = 0.0061);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at